At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 90 enrolled
Drug / intervention
Testosterone +1 moredrug
Likely dose
Testosterone 300mcgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Hormonal Factors in the Treatment of Anorexia Nervosa
In Brief
A Phase 2 clinical trial evaluating Testosterone and Placebo for Anorexia Nervosa and 3 related conditions. Completed, enrolled 90 participants across 1 site.
Detailed Summary
The investigators are investigating whether a hormone that is naturally produced by the human body, called testosterone, can help improve weight, disordered eating, depression, and anxiety. The investigators hypothesize that testosterone will be a novel and effective endocrine-targeted therapy for patients with anorexia nervosa.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnorexia Nervosa, Eating Disorder, Anxiety, Depression
CountriesUnited States
CollaboratorsNational Institute of Mental Health (NIMH)
Timeline
Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartApr 2010
First PostedMay 2010
Primary CompletionFeb 2016
TodayJul 2026
First PostedMay 12, 2010
Enrollment StartApr 1, 2010
Primary CompletionFeb 1, 2016
TodayJul 2, 2026
Enrollment to primary: 5.8 yearsPosted 16.1 years ago
Interventions
Testosteronedrug
Testosterone 300mcg transdermal patch x 24 weeks.
Placebodrug
Placebo transdermal patch x 24 weeks